Two Sigma Investments, LP Better Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.1 - $1.74 $7,350 - $11,626	-6,682 Reduced 35.4%	12,192 $13,000
Q3 2022 Nov 14, 2022	SELL	$1.53 - $2.77 $84,036 - $152,145	-54,926 Reduced 74.43%	18,874 $33,000
Q2 2022 Aug 15, 2022	BUY	$0.91 - $2.34 $7,287 - $18,738	8,008 Added 12.17%	73,800 $115,000
Q1 2022 May 16, 2022	SELL	$1.98 - $5.01 $116,734 - $295,374	-58,957 Reduced 47.26%	65,792 $130,000
Q4 2021 Feb 14, 2022	BUY	$4.58 - $17.14 $571,350 - $2.14 Million	124,749 New	124,749 $580,000

Ticker BTTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,743,000
Description
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.